Guanbin XIE and Haidong YU from Lifang & Partners identify the key clauses of a patent license agreement and discuss – from a practical standpoint – how the clauses should be drafted and reviewed.

Namir Sioufi, Saba IP, explores patent law in the MENA region in relation to the growing Biopharma market, looking closely at the similarities and differences of the regions involved.

Sergio L. Olivares, Jr. and Mauricio Sámano from Olivares discuss the Mexican patent scenario, considering the aspects that work well and those that need more development to be able to protect inventors.

Bob Stembridge, Clarivate Analytics, explains how Derwent Innovation can easily and accurately establish the current status and ownership of a patent making the process faster and easier.

José Alberto Campos-Vargas, Sánchez Devanny, explore the new regulations, challenges, and opportunities for technology developers in Mexico.

Marisa Moura Momoli and Priscila Kurdian Castanho Afonso, Di Blasi Parente & Associados, outline the recently introduced Joint Ordinance No. 1 that has settled a 15-year long dispute between the BPTO and ANVISA.

Swatika Taneja, from KPaSeAn, highlights the importance of patent filing by thinking about biopiracy and its effect on developing countries.

Piotr Dynowski and Piotr Zawadzki from Bird & Bird discuss the patentability of computer-implemented inventions in Poland, closely considering criticism of the system and necessary updates for the system to work more efficiently and sustainably

MIN Dan, ZY Partners, investigates the first SPC model case for bio-tech patents: PRB, Novozymes vs. Longda/Boli.

Dr. Jason Xue, Jiaquan IP Law, outlines two specific cases that are used to analyze the examination standard of Article 33 of the Patent Law.

Pham Vu Khanh Toan, Managing Partner at Pham & Associates, explores patent prosecution in Vietnam by explaining the current laws and practices in the country.